Study Conduct

Frenova’s F1RST Up, other industry alliances to speed clinical study startup

Monday, February 22, 2016

Frenova, the only phase I-IV drug and device clinical development services provider dedicated exclusively to renal research, is launching an alliance to accelerate clinical study startup. Named F1RST Up, for Frenova Rapid STart Up, the exclusive alliance connects physicians with recognized as leaders in nephrology research. The purpose of the alliance is to remove the administrative and contract obstacles that often impede clinical trials.

[Read More]

Unique patient center is opening lines of communication

Monday, February 22, 2016

A first-of-its-kind initiative to enhance communication between patient groups, the medical science industry and clinical research institutions has bloomed in Illinois, with the hope that the concept will broaden throughout the country to help produce better medical innovation outcomes.

[Read More]

Worldwide Clinical Trials marks Rare Disease Day with trial design webinar

Friday, February 19, 2016

Rare Disease Day, set for February 29, is intended to raise awareness around the world about rare diseases and their impact on patient lives. Worldwide Clinical Trials will mark the day with a free webcast that demonstrates new perspectives on the study of rare diseases, highlighting the need for the industry to rethink its approach to clinical trial design and execution within this complex area of medicine.

[Read More]